NUK - logo

Rezultati iskanja

Osnovno iskanje    Ukazno iskanje   

Trenutno NISTE avtorizirani za dostop do e-virov NUK. Za polni dostop se PRIJAVITE.

1 2 3 4 5
zadetkov: 423
1.
  • Consensus Expert Recommenda... Consensus Expert Recommendations for the Diagnosis and Management of Autosomal Recessive Polycystic Kidney Disease: Report of an International Conference
    Guay-Woodford, Lisa M., MD; Bissler, John J., MD; Braun, Michael C., MD ... The Journal of pediatrics, 09/2014, Letnik: 165, Številka: 3
    Journal Article, Conference Proceeding
    Recenzirano
    Odprti dostop

    Autosomal recessive polycystic kidney disease (ARPKD; MIM 263200) is a severe, typically early onset form of cystic disease that primarily involves the kidneys and biliary tract. Phenotypic ...
Celotno besedilo

PDF
2.
Celotno besedilo

PDF
3.
  • Neonatal Cholestasis
    Lane, Erin; Murray, Karen F The Pediatric clinics of North America, 06/2017, Letnik: 64, Številka: 3
    Journal Article
    Recenzirano

    Neonatal jaundice is common and usually not concerning when it is secondary to unconjugated hyperbilirubinemia, below the neurotoxic level, and resolves early. Primary care providers should be ...
Preverite dostopnost
4.
  • Alanine Aminotransferase an... Alanine Aminotransferase and Gamma‐Glutamyl Transpeptidase Predict Histologic Improvement in Pediatric Nonalcoholic Steatohepatitis
    Newton, Kimberly P.; Lavine, Joel E.; Wilson, Laura ... Hepatology (Baltimore, Md.), March 2021, Letnik: 73, Številka: 3
    Journal Article
    Recenzirano
    Odprti dostop

    Background and Aims Predictive, noninvasive tools are needed to monitor key features of nonalcoholic fatty liver disease (NAFLD) in children that relate to improvement in liver histology. The purpose ...
Celotno besedilo

PDF
5.
  • The safety and effectivenes... The safety and effectiveness of ledipasvir−sofosbuvir in adolescents 12‐17 years old with hepatitis C virus genotype 1 infection
    Balistreri, William F.; Murray, Karen F.; Rosenthal, Philip ... Hepatology (Baltimore, Md.), August 2017, 2017-08-00, 20170801, Letnik: 66, Številka: 2
    Journal Article
    Recenzirano
    Odprti dostop

    No all‐oral, direct‐acting antiviral regimens have been approved for children with chronic hepatitis C virus (HCV) infection. We conducted a phase 2, multicenter, open‐label study to evaluate the ...
Celotno besedilo
6.
  • Histological Abnormalities ... Histological Abnormalities in Children with Nonalcoholic Fatty Liver Disease and Normal or Mildly Elevated Alanine Aminotransferase Levels
    Molleston, Jean P., MD; Schwimmer, Jeffrey B., MD; Yates, Katherine P., MD ... The Journal of pediatrics, 04/2014, Letnik: 164, Številka: 4
    Journal Article
    Recenzirano
    Odprti dostop

    Objective To investigate the histological spectrum of nonalcoholic fatty liver disease (NAFLD) in children with normal, mildly elevated (26-50 U/L boys, 23-44 U/L girls), or elevated (>50 U/L in ...
Celotno besedilo

PDF
7.
  • Ledipasvir‐Sofosbuvir for 1... Ledipasvir‐Sofosbuvir for 12 Weeks in Children 3 to <6 Years Old With Chronic Hepatitis C
    Schwarz, Kathleen B.; Rosenthal, Philip; Murray, Karen F. ... Hepatology (Baltimore, Md.), February 2020, Letnik: 71, Številka: 2
    Journal Article
    Recenzirano
    Odprti dostop

    For children under 12 years of age who have chronic hepatitis C virus (HCV) infection, there are currently no approved treatments with direct‐acting antiviral agents. We therefore evaluated the ...
Celotno besedilo

PDF
8.
  • Sofosbuvir and ribavirin in... Sofosbuvir and ribavirin in adolescents 12‐17 years old with hepatitis C virus genotype 2 or 3 infection
    Wirth, Stefan; Rosenthal, Philip; Gonzalez‐Peralta, Regino P. ... Hepatology (Baltimore, Md.), October 2017, 2017-10-00, 20171001, Letnik: 66, Številka: 4
    Journal Article
    Recenzirano
    Odprti dostop

    Children with chronic hepatitis C virus infection have limited treatment options. We evaluated the all‐oral combination of sofosbuvir and ribavirin in adolescents aged 12‐17 with hepatitis C virus ...
Celotno besedilo

PDF
9.
  • Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial
    Lavine, Joel E; Schwimmer, Jeffrey B; Van Natta, Mark L ... JAMA : the journal of the American Medical Association, 2011-Apr-27, Letnik: 305, Številka: 16
    Journal Article
    Recenzirano

    Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in US children and adolescents and can present with advanced fibrosis or nonalcoholic steatohepatitis (NASH). No ...
Preverite dostopnost


PDF
10.
  • Safety and Efficacy of Ledi... Safety and Efficacy of Ledipasvir–Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6‐11
    Murray, Karen F.; Balistreri, William F.; Bansal, Sanjay ... Hepatology (Baltimore, Md.), December 2018, 2018-12-00, 20181201, Letnik: 68, Številka: 6
    Journal Article
    Recenzirano

    Currently, there are no interferon‐free treatments available for hepatitis C virus (HCV)–infected patients younger than 12 years. We evaluated the safety and effectiveness of the all‐oral regimen ...
Celotno besedilo
1 2 3 4 5
zadetkov: 423

Nalaganje filtrov